The Fortin Drug Discovery Laboratory is working to discover small molecules to treat protein-folding, neuropathologic, and neurotoxicologic disorders. Current investigations include therapeutic strategies for neurodegenerative diseases and type 2 diabetes, neurotoxicity and dysfunction in basal ganglia pathways, and diagnostic investigation of protein-folding disorders.
Tuesday, November 12, 2019, ACVP and ASVCP Concurrent Annual Meeting
Kos NS, Thompson TL, Isa NBM, Rashid AM, O’Dell M, Fortin JS.
In vitro evaluation of small molecule inhibitors of feline islet amyloid polypeptide fibrillogenesis.